PARP1 and cancer: Given the variability of cellular levels of NAD+ across different organs and the numerous mechanisms of NAD+ biosynthetic pathways that are altered in cancer (18,19), clarifying the essential role of NAD+ in PARP1 activation and the cellular response to DNA damage is essential (16).